Drug Profile
BBR 3464
Alternative Names: BBR-3464Latest Information Update: 09 Mar 2010
Price :
$50
*
At a glance
- Originator Roche
- Class Antineoplastics; Platinum complexes
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Gastric cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Small cell lung cancer